Physician profile
Michael Hoffman
NPI 1841276425
$520.15
in general payments reported to CMS, 2019-2025
10 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.61 · 2023: $120 · 2024: $174 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.72 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $136.36 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $101.66 | 2022-2024 | Dupixent |
| Glaxosmithkline, LLC. | $77.98 | 2025 | Nucala |
| Optinose US, INC. | $41.10 | 2024-2025 | |
| Genzyme Corporation | $39.98 | 2023 | |
| Acclarent, INC | $31.57 | 2023 | Trudi Nav Cable |
| Smith+Nephew, INC. | $29.99 | 2024 | Rapid Rhino, Rf20000, Tula |
| Eclipse Technology Solutions INC. | $20.79 | 2023 | |
| Medtronic, INC. | $20.63 | 2025 | Propel |
| Ars Pharmaceuticals Operations, INC. | $20.09 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.